Roche Launches 454 Sequencer as Industry Takes Shape and Rivals Scramble to Catch Up | GenomeWeb

454 Life Sciences and its marketing partner, Roche Applied Science, announced last week that they had launched 454's new DNA sequencer, the first of a new wave of competing sequencing technologies expected to hit the market over the next year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.